---
document_datetime: 2025-11-23 07:46:49
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/sustiva.html
document_name: sustiva.html
version: success
processing_time: 0.1057273
conversion_datetime: 2025-12-26 17:19:42.311195
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Sustiva

[RSS](/en/individual-human-medicine.xml/66062)

##### Withdrawn

This medicine's authorisation has been withdrawn

efavirenz

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Sustiva](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 1 February 2024, the European Commission withdrew the marketing authorisation for Sustiva (efavirenz) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Bristol-Myers Squibb Pharma EEIG, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Sustiva was granted marketing authorisation in the EU on 28 May 1999 for treatment of HIV-1 infection. The marketing authorisation was initially valid for a 5-year period. It was subsequently renewed for an additional 5-year period in 2004, and in 2009. It was then granted unlimited validity in 2014.

There are generic medicinal products of efavirenz authorised and marketed in the EU.

The European Public Assessment Report (EPAR) for Sustiva is updated to indicate that the marketing authorisation is no longer valid.

Sustiva : EPAR - Summary for the public

English (EN) (182.37 KB - PDF)

**First published:** 30/04/2009

**Last updated:** 14/03/2024

[View](/en/documents/overview/sustiva-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-210)

български (BG) (258.97 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/bg/documents/overview/sustiva-epar-summary-public_bg.pdf)

español (ES) (182.72 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/es/documents/overview/sustiva-epar-summary-public_es.pdf)

čeština (CS) (233.12 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/cs/documents/overview/sustiva-epar-summary-public_cs.pdf)

dansk (DA) (182.24 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/da/documents/overview/sustiva-epar-summary-public_da.pdf)

Deutsch (DE) (193.92 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/de/documents/overview/sustiva-epar-summary-public_de.pdf)

eesti keel (ET) (174.51 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/et/documents/overview/sustiva-epar-summary-public_et.pdf)

ελληνικά (EL) (267.72 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/el/documents/overview/sustiva-epar-summary-public_el.pdf)

français (FR) (190.13 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/fr/documents/overview/sustiva-epar-summary-public_fr.pdf)

hrvatski (HR) (225.5 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/hr/documents/overview/sustiva-epar-summary-public_hr.pdf)

italiano (IT) (182.03 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/it/documents/overview/sustiva-epar-summary-public_it.pdf)

latviešu valoda (LV) (231.22 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/lv/documents/overview/sustiva-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (231.23 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/lt/documents/overview/sustiva-epar-summary-public_lt.pdf)

magyar (HU) (218.78 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/hu/documents/overview/sustiva-epar-summary-public_hu.pdf)

Malti (MT) (236.46 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/mt/documents/overview/sustiva-epar-summary-public_mt.pdf)

Nederlands (NL) (187.4 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/nl/documents/overview/sustiva-epar-summary-public_nl.pdf)

polski (PL) (234.35 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/pl/documents/overview/sustiva-epar-summary-public_pl.pdf)

português (PT) (185.1 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/pt/documents/overview/sustiva-epar-summary-public_pt.pdf)

română (RO) (239.14 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/ro/documents/overview/sustiva-epar-summary-public_ro.pdf)

slovenčina (SK) (228.61 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/sk/documents/overview/sustiva-epar-summary-public_sk.pdf)

slovenščina (SL) (218.25 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/sl/documents/overview/sustiva-epar-summary-public_sl.pdf)

Suomi (FI) (176.01 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/fi/documents/overview/sustiva-epar-summary-public_fi.pdf)

svenska (SV) (181.1 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/sv/documents/overview/sustiva-epar-summary-public_sv.pdf)

## Product information

Sustiva : EPAR - Product Information

English (EN) (5.86 MB - PDF)

**First published:** 16/11/2009

**Last updated:** 14/03/2024

[View](/en/documents/product-information/sustiva-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-807)

български (BG) (17.63 MB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/bg/documents/product-information/sustiva-epar-product-information_bg.pdf)

español (ES) (6.36 MB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/es/documents/product-information/sustiva-epar-product-information_es.pdf)

čeština (CS) (14.64 MB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/cs/documents/product-information/sustiva-epar-product-information_cs.pdf)

dansk (DA) (5.99 MB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/da/documents/product-information/sustiva-epar-product-information_da.pdf)

Deutsch (DE) (7.34 MB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/de/documents/product-information/sustiva-epar-product-information_de.pdf)

eesti keel (ET) (5.79 MB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/et/documents/product-information/sustiva-epar-product-information_et.pdf)

ελληνικά (EL) (19.02 MB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/el/documents/product-information/sustiva-epar-product-information_el.pdf)

français (FR) (6.46 MB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/fr/documents/product-information/sustiva-epar-product-information_fr.pdf)

hrvatski (HR) (11.79 MB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/hr/documents/product-information/sustiva-epar-product-information_hr.pdf)

íslenska (IS) (5.93 MB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/is/documents/product-information/sustiva-epar-product-information_is.pdf)

italiano (IT) (82.01 KB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/it/documents/product-information/sustiva-epar-product-information_it.pdf)

latviešu valoda (LV) (100.85 KB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/lv/documents/product-information/sustiva-epar-product-information_lv.pdf)

lietuvių kalba (LT) (101.06 KB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/lt/documents/product-information/sustiva-epar-product-information_lt.pdf)

magyar (HU) (11.05 MB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/hu/documents/product-information/sustiva-epar-product-information_hu.pdf)

Malti (MT) (101.59 KB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/mt/documents/product-information/sustiva-epar-product-information_mt.pdf)

Nederlands (NL) (83.32 KB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/nl/documents/product-information/sustiva-epar-product-information_nl.pdf)

norsk (NO) (5.92 MB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/no/documents/product-information/sustiva-epar-product-information_no.pdf)

polski (PL) (100.82 KB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/pl/documents/product-information/sustiva-epar-product-information_pl.pdf)

português (PT) (82.47 KB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/pt/documents/product-information/sustiva-epar-product-information_pt.pdf)

română (RO) (95.5 KB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/ro/documents/product-information/sustiva-epar-product-information_ro.pdf)

slovenčina (SK) (96.27 KB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/sk/documents/product-information/sustiva-epar-product-information_sk.pdf)

slovenščina (SL) (90.6 KB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/sl/documents/product-information/sustiva-epar-product-information_sl.pdf)

Suomi (FI) (6.21 MB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/fi/documents/product-information/sustiva-epar-product-information_fi.pdf)

svenska (SV) (82.81 KB - PDF)

**First published:**

16/11/2009

**Last updated:**

14/03/2024

[View](/sv/documents/product-information/sustiva-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** N/0161 23/05/2023

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Sustiva : EPAR - All Authorised presentations

English (EN) (82.79 KB - PDF)

**First published:** 30/04/2009

**Last updated:** 14/03/2024

[View](/en/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-778)

български (BG) (106.92 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/bg/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_bg.pdf)

español (ES) (82.95 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/es/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_es.pdf)

čeština (CS) (91.71 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/cs/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (83.65 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/da/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (84.27 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/de/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (83.76 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/et/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (98.05 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/el/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_el.pdf)

français (FR) (83.23 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/fr/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (98.88 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/hr/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (83.88 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/is/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_is.pdf)

italiano (IT) (82.01 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/it/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (100.85 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/lv/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (101.06 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/lt/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (101.33 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/hu/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (101.59 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/mt/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (83.32 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/nl/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (83.73 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/no/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_no.pdf)

polski (PL) (100.82 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/pl/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_pl.pdf)

português (PT) (82.47 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/pt/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_pt.pdf)

română (RO) (95.5 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/ro/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (96.27 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/sk/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (90.6 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/sl/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (81.93 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/fi/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (82.81 KB - PDF)

**First published:**

30/04/2009

**Last updated:**

14/03/2024

[View](/sv/documents/all-authorised-presentations/sustiva-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Sustiva Active substance efavirenz International non-proprietary name (INN) or common name efavirenz Therapeutic area (MeSH) HIV Infections Anatomical therapeutic chemical (ATC) code J05AG03

### Pharmacotherapeutic group

Antivirals for systemic use

### Therapeutic indication

Sustiva is indicated in antiviral combination treatment of human-immunodeficiency-virus-1 (HIV-1)-infected adults, adolescents and children three years of age and older.

Sustiva has not been adequately studied in patients with advanced HIV disease, namely in patients with CD4 counts &lt; 50 cells/mm 3 , or after failure of protease-inhibitor (PI)-containing regimens. Although cross-resistance of efavirenz with PIs has not been documented, there are at present insufficient data on the efficacy of subsequent use of PI-based combination therapy after failure of regimens containing Sustiva.

## Authorisation details

EMA product number EMEA/H/C/000249 Marketing authorisation holder

Bristol-Myers Squibb Pharma EEIG

Plaza 254

Opinion adopted 24/02/1999 Marketing authorisation issued 28/05/1999 Withdrawal of marketing authorisation 01/02/2024 Revision 48

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Sustiva : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (1.56 MB - PDF)

**First published:** 16/11/2006

**Last updated:** 14/03/2024

[View](/en/documents/procedural-steps-after/sustiva-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

Sustiva-H-C-PSUSA-00001200-201804 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Reference Number: EMA/132484/2019

English (EN) (116.29 KB - PDF)

**First published:** 27/05/2019

**Last updated:** 14/03/2024

[View](/en/documents/scientific-conclusion/sustiva-h-c-psusa-00001200-201804-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf)

Sustiva-H-C-249-II-0126-G : EPAR - Scientific Discussion - Variation

Adopted

Reference Number: EMA/260283/2015

English (EN) (4.13 MB - PDF)

**First published:** 19/05/2015

**Last updated:** 14/03/2024

[View](/en/documents/scientific-discussion-variation/sustiva-h-c-249-ii-0126-g-epar-scientific-discussion-variation_en.pdf)

CHMP post-authorisation summary of positive opinion for Sustiva

Adopted

Reference Number: EMA/CHMP/104007/2015

English (EN) (103.24 KB - PDF)

**First published:** 27/02/2015

**Last updated:** 14/03/2024

[View](/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-sustiva_en.pdf)

Sustiva-H-C-249-P45-0056: EPAR - Assessment Report

Adopted

Reference Number: EMA/815692/2012

English (EN) (187.48 KB - PDF)

**First published:** 20/12/2012

**Last updated:** 14/03/2024

[View](/en/documents/variation-report/sustiva-h-c-249-p45-0056-epar-assessment-report_en.pdf)

Sustiva : EPAR - Steps taken after authorisation when a cutoff date has been used

English (EN) (263.13 KB - PDF)

**First published:** 20/11/2006

**Last updated:** 14/03/2024

[View](/en/documents/steps-after-cutoff/sustiva-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf)

## Initial marketing authorisation documents

Sustiva : EPAR - Scientific Discussion

English (EN) (1.5 MB - PDF)

**First published:** 20/11/2006

**Last updated:** 14/03/2024

[View](/en/documents/scientific-discussion/sustiva-epar-scientific-discussion_en.pdf)

Sustiva : EPAR - Procedural steps taken before authorisation

English (EN) (136.79 KB - PDF)

**First published:** 20/11/2006

**Last updated:** 14/03/2024

[View](/en/documents/procedural-steps/sustiva-epar-procedural-steps-taken-authorisation_en.pdf)

#### News on Sustiva

[Updated advice on body fat changes and lactic acidosis with HIV medicines](/en/news/updated-advice-body-fat-changes-lactic-acidosis-hiv-medicines) 23/10/2015

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 October 2015](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-19-22-october-2015) 23/10/2015

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 February 2015](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-23-26-february-2015) 27/02/2015

**This page was last updated on** 14/03/2024

## Share this page

[Back to top](#main-content)